Holen Sie sich die Stockscreener-App
0.9411
0.88%
0.0082
Handel nachbörslich:
.91
-0.0311
-3.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.9329
Offen:
$0.93
24-Stunden-Volumen:
122.95K
Relative Volume:
0.68
Marktkapitalisierung:
$59.07M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-2.6273
EPS:
-0.3582
Netto-Cashflow:
$-19.17M
1W Leistung:
+0.28%
1M Leistung:
-12.86%
6M Leistung:
-16.72%
1J Leistung:
-33.73%
1-Tages-Spanne:
$0.925
$0.9499
1-Wochen-Bereich:
$0.8663
$0.9499
52-Wochen-Spanne:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Firmenname
Cytosorbents Corp
Sektor
Branche
Telefon
973-329-8885
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Vergleichen Sie CTSO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.9411 | 58.55M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-09-17 | Eingeleitet | Jefferies | Buy |
| 2020-09-01 | Eingeleitet | SVB Leerink | Outperform |
| 2017-08-08 | Bestätigt | Maxim Group | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-05-24 | Eingeleitet | Maxim Group | Buy |
| 2015-10-29 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Bestätigt | MLV & Co | Buy |
| 2015-04-01 | Bestätigt | MLV & Co | Buy |
| 2015-03-05 | Eingeleitet | MLV & Co | Buy |
| 2015-02-25 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-01-27 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
Can technical indicators confirm Cytosorbents Corporation’s reversal2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
Using R and stats models for Cytosorbents Corporation forecastingBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
How moving averages guide Cytosorbents Corporation trading2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Order flow analysis tools used on Cytosorbents CorporationWeekly Investment Report & Fast Entry Momentum Alerts - newser.com
Cytosorbents (NASDAQ:CTSO) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Quantitative breakdown of Cytosorbents Corporation recent moveGlobal Markets & Real-Time Stock Entry Alerts - newser.com
Visual trend scoring systems applied to Cytosorbents CorporationJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com
How hedge fund analytics apply to Cytosorbents Corporation stockOptions Play & Step-by-Step Trade Execution Guides - newser.com
Can Cytosorbents Corporation rally from current levelsGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Cytosorbents Corporation stock outlook for YEARJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
What does recent volatility data suggest for Cytosorbents CorporationJuly 2025 Technicals & AI Driven Price Forecasts - newser.com
Advanced analytics toolkit walkthrough for Cytosorbents CorporationGap Down & Weekly Market Pulse Updates - newser.com
CytoSorbents provides DrugSorb-ATR regulatory update - TipRanks
CytoSorbents (CTSO) Prepares New FDA Application for DrugSorb-AT - GuruFocus
FDA Provides Expedited Path Forward: CytoSorbents' Breakthrough Device DrugSorb-ATR Gets New Life - Stock Titan
How to track smart money flows in Cytosorbents CorporationQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
how to track smart money flows in cytosorbents corporationGap Down & Low Risk Growth Stock Ideas - newser.com
Cytosorbents Corporation stock trend forecastTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
What to expect from Cytosorbents Corporation in the next 30 daysGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
Custom strategy builders for tracking Cytosorbents Corporation2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
Using AI based signals to follow Cytosorbents CorporationJuly 2025 Outlook & Growth Focused Entry Reports - Newser
Has Cytosorbents Corporation formed a bullish divergenceTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Institutional scanner results for Cytosorbents CorporationMarket Activity Recap & Daily Technical Forecast Reports - Newser
Can swing trading help recover from Cytosorbents Corporation lossesWall Street Watch & Stock Portfolio Risk Control - Newser
Is Cytosorbents Corporation meeting your algorithmic filter criteriaQuarterly Profit Summary & Weekly Watchlist of Top Performers - Newser
Granahan Investment Management LLC Has $358,000 Position in Cytosorbents Corporation $CTSO - MarketBeat
What Fibonacci levels say about Cytosorbents Corporation reboundJuly 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
What’s the recovery path for long term holders of Cytosorbents Corporation2025 Valuation Update & AI Based Buy and Sell Signals - Newser
What’s next for Cytosorbents Corporation stock priceM&A Rumor & Daily Stock Trend Reports - Newser
Is Cytosorbents Corporation forming a reversal patternStop Loss & Safe Entry Momentum Tips - Newser
Earnings visualization tools for Cytosorbents CorporationQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Developing predictive dashboards with Cytosorbents Corporation dataWeekly Trade Summary & Verified Short-Term Trading Plans - Newser
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):